This page was reviewed under our medical and editorial policy by
Maurie Markman, MD, President, Medicine & Science
This page was updated on October 29, 2021.
A positron emission tomography (PET) scan is an advanced nuclear imaging technique used to look for cancer and its spread. PET scanners trace a form of radioactive sugar as it’s absorbed by the body's cells. Because cancer cells grow quickly, they take up larger amounts of sugar (glucose) than normal cells. The patient will drink or be injected with the sugary tracer before the test.
During the nuclear medicine scan, the patient rests on a table and slides into a large, tunnel-shaped scanner. The outpatient procedure is painless and varies in length, depending on the part of the body being evaluated.
This advanced nuclear imaging technique combines a PET scan and a computed tomography scan (CT) into one machine. A CT scan is similar to traditional X-rays. However, it takes pictures in thin slices from different angles. A computer is used to compile these thin slices and create a 3D picture of the X-rayed area. The combination of CT and PET imaging reveals information about both the structure (from the CT scan) and the function (from the PET scan) of cells and tissues in the body during a single session.
Compared with an X-ray or magnetic resonance imaging (MRI) scan, a PET/CT enables doctors to examine medical conditions and abnormalities at a cellular level.
Whereas CT scans take pictures from a variety of angles to show images of the patient's body organs, tissues and bones, the PET scan shows how the patient's cells react to a radiotracer, which may indicate cancerous areas. The combined PET/CT scan joins these two technologies together.
A PET/MRI scan is used to obtain anatomic and quantitative information from an MRI at the same time as physiologic information from PET imaging. The advantage of a PET/MRI is that it shows soft tissue more clearly. Soft tissue cancers occur most frequently in connective tissue and are often found in the legs and pelvis. They may also develop in the arms and upper body.
The PET/CT scanner is able to "see'' damaged or cancerous cells where the radiotracer mixture is being taken up. The rate at which the tumor is using the sugary substance may help determine the tumor grade in some tumors. This helps stage your tumor by determining which parts of the body have abnormal activity.
By combining information about the body's anatomy and metabolic function, a PET/CT scan provides a more detailed picture of cancerous tissues than either test does alone. The PET and CT images appear in a single scan, allowing for a high level of accuracy. The use of PET/CT scan helps the oncology team develop the optimal cancer treatment plan. Follow-up may involve additional testing and biopsy or treatment protocols, such as radiation therapy and chemotherapy.
Many oncologists perform a CT scan and/or a bone scan prior to ordering a PET/CT scan.
A PET/CT scan may also:
A PET/CT scan can be more sensitive than other imaging tests and may find cancer sooner than other tests do. Not all tumors take up the radiotracer, but PET/CT is highly accurate in differentiating from the benign and malignant tumors it finds, particularly in some cancers such as lung and musculoskeletal tumors.
While the benefits of a PET/CT generally outweigh the risks, there are some risks.
A radiologist who specializes in reading PET/CT scans will interpret the images and report back to the doctor who ordered the procedure.
The radiologist’s report will include:
How long it takes for your doctor (the ordering physician) to get your results depends on a number of factors:
Don’t be afraid to ask the facility when your doctor is likely to receive the report.